{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:27:24Z","timestamp":1793039244233,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.humimm.2017.03.012","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T10:32:25Z","timestamp":1490956345000},"page":"421-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome"],"prefix":"10.1016","volume":"78","author":[{"given":"David F.","family":"Pinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Friedewald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley M.K.","family":"Haarberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shree L.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Zitzner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy E.","family":"Hanshew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat R.","family":"Tambur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.humimm.2017.03.012_b0005","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1056\/NEJM196904032801401","article-title":"Significance of the positive crossmatch test in kidney transplantation","volume":"280","author":"Patel","year":"1969","journal-title":"N. Engl. J. Med."},{"issue":"9470","key":"10.1016\/j.humimm.2017.03.012_b0010","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/S0140-6736(05)66458-6","article-title":"Transplant, non-HLA transplantation immunity revealed by lymphocytotoxic antibodies","volume":"365","author":"Opelz","year":"2005","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.humimm.2017.03.012_b0015","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.tp.0000231348.55262.5a","article-title":"Endothelial cells as targets of allograft rejection","volume":"82","author":"Glotz","year":"2006","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.humimm.2017.03.012_b0020","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1111\/j.1600-6143.2009.02819.x","article-title":"Effect of antibodies on endothelium","volume":"9","author":"Zhang","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.humimm.2017.03.012_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2016.05.021","article-title":"Pathogenesis of non-HLA antibodies in solid organ transplantation: where do we stand?","author":"Delville","year":"2016","journal-title":"Hum. Immunol."},{"issue":"5302","key":"10.1016\/j.humimm.2017.03.012_b0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1126\/science.275.5302.964","article-title":"Isolation of putative progenitor endothelial cells for angiogenesis","volume":"275","author":"Asahara","year":"1997","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.humimm.2017.03.012_b0035","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/TP.0b013e3181949d4e","article-title":"Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation","volume":"87","author":"Breimer","year":"2009","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2017.03.012_b0040","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1600-6143.2011.03955.x","article-title":"Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody","volume":"12","author":"Jackson","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2017.03.012_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.transproceed.2010.12.040","article-title":"XM-ONE detection of endothelium cell antibodies identifies a subgroup of HLA-antibody negative patients undergoing acute rejection","volume":"43","author":"Xavier","year":"2011","journal-title":"Transplant. Proc."},{"issue":"11","key":"10.1016\/j.humimm.2017.03.012_b0050","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.humimm.2013.06.007","article-title":"A prospective study evaluating the role of donor-specific anti-endothelial crossmatch (XM-ONE assay) in predicting living donor kidney transplant outcome","volume":"74","author":"Zitzner","year":"2013","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.humimm.2017.03.012_b0055","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.humimm.2017.03.012_b0060","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.cmet.2011.03.001","article-title":"AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure","volume":"13","author":"Gurley","year":"2011","journal-title":"Cell Metab."},{"issue":"7","key":"10.1016\/j.humimm.2017.03.012_b0065","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI4106","article-title":"Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor","volume":"103","author":"Wallukat","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.humimm.2017.03.012_b0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJMoa035717","article-title":"Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection","volume":"352","author":"Dragun","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.humimm.2017.03.012_b0075","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0b013e3181fd97f1","article-title":"Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients","volume":"90","author":"Reinsmoen","year":"2010","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.humimm.2017.03.012_b0080","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1111\/ajt.12395","article-title":"Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies","volume":"13","author":"Taniguchi","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"10","key":"10.1016\/j.humimm.2017.03.012_b0085","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/ajt.12397","article-title":"Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss","volume":"13","author":"Giral","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"9","key":"10.1016\/j.humimm.2017.03.012_b0090","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182692ad2","article-title":"Non-HLA antibodies targeting vascular receptors enhance alloimmune response and microvasculopathy after heart transplantation","volume":"94","author":"Hiemann","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.humimm.2017.03.012_b0095","article-title":"Anti-angiotensin II type 1 receptor and anti-endothelial cell antibodies: a cross-sectional analysis of pathological findings in allograft biopsies","author":"Philogene","year":"2016","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.humimm.2017.03.012_b0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2017.03.012_b0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/TP.0b013e31821b60e9","article-title":"Clinical relevance and IgG subclass determination of non-HLA antibodies identified using endothelial cell precursors isolated from donor blood","volume":"92","author":"Jackson","year":"2011","journal-title":"Transplantation"},{"issue":"13","key":"10.1016\/j.humimm.2017.03.012_b0110","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa067160","article-title":"Antibodies against MICA antigens and kidney-transplant rejection","volume":"357","author":"Zou","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.humimm.2017.03.012_b0115","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","article-title":"Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation","volume":"71","author":"Jurcevic","year":"2001","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.humimm.2017.03.012_b0120","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.healun.2011.01.708","article-title":"Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts","volume":"30","author":"Saini","year":"2011","journal-title":"J. Heart Lung Transplant."},{"issue":"1","key":"10.1016\/j.humimm.2017.03.012_b0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00007890-199001000-00019","article-title":"The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection","volume":"49","author":"Halloran","year":"1990","journal-title":"Transplantation"},{"issue":"3","key":"10.1016\/j.humimm.2017.03.012_b0130","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/00007890-199203000-00011","article-title":"The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody","volume":"53","author":"Halloran","year":"1992","journal-title":"Transplantation"},{"issue":"11","key":"10.1016\/j.humimm.2017.03.012_b0135","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure","volume":"9","author":"Einecke","year":"2009","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.humimm.2017.03.012_b0140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.humimm.2012.07.010","article-title":"Non-HLA-antibodies targeting Angiotensin type 1 receptor and antibody mediated rejection","volume":"73","author":"Dragun","year":"2012","journal-title":"Hum. Immunol."},{"issue":"20","key":"10.1016\/j.humimm.2017.03.012_b0145","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1009546","article-title":"Alemtuzumab induction in renal transplantation","volume":"364","author":"Hanaway","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.humimm.2017.03.012_b0150","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/ctr.12665","article-title":"Clinical relevance of preformed IgG and IgM antibodies against donor endothelial progenitor cells in recipients of living donor kidney grafts","volume":"30","author":"Daniel","year":"2016","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.humimm.2017.03.012_b0155","article-title":"Non-HLA antibodies may accelerate immune responses after intestinal and multivisceral transplantation","author":"Gerlach","year":"2016","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.humimm.2017.03.012_b0160","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/petr.12728","article-title":"Angiotensin II type 1 receptor antibodies in childhood kidney transplantation","volume":"20","author":"Bjerre","year":"2016","journal-title":"Pediatr. Transplant."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885917300629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T20:00:42Z","timestamp":1750190442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885917300629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":32,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0198885917300629"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2017.03.012","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the potential of angiotensin II type 1 receptor and donor specific anti-endothelial cell antibodies to predict long-term kidney graft outcome","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2017.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}